Oregon Attorney General Dan Rayfield filed a $900 million lawsuit against the nation’s largest insulin manufacturers, ...

The lawsuit alleges three manufacturers coordinated with three pharmacy benefit managers in a scheme to inflate insulin ...

Explore India's urgent need to bridge the healthcare gap for children with Type 1 Diabetes (T1D) by ensuring universal access ...

Insulin is often cited as a prime example of soaring drug costs after years of price hike by drug manufacturers.

The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...

Peptides are everywhere; they’re unavoidable. Insulin is a peptide. So are GLP-1s—the Ozempics and Mounjaros of the world.

WANNABE slimmers were today urged not to suddenly restart fat jabs at the same dose after pressing pause over Christmas.

Dutasteride is another 5-alpha reductase inhibitor, like finasteride, which works by blocking the male hormone DHT to stop ...

Explore gray-market "Chinese peptides," which are popular in the tech world, but pose serious safety risks, according to the ...

In the fight against climate change, companies are navigating compounding problems: supply-chain issues, tariffs, changing ...